BBC moderator dies of blood clot following AstraZeneca jab


Her family revealed that an award-winning BBC radio presenter died last week after having a blood clot after vaccination with the AstraZeneca COVID-19 jab.

Lisa Shaw, who worked at the BBC Newcastle, developed a “severe” headache a week after receiving the CCP (Chinese Communist Party) virus vaccine and fell into a serious condition a few days later, her family said Thursday. Said in a statement.

A 44-year-old 1-year-old mother received intensive care due to blood clots and bleeding, but died on May 21 at the Royal Victoria Clinic in Newcastle.

“We are overwhelmed and there are Lisa-shaped holes in our lives that can never be filled,” her family said. “We will always love and miss her. . “

The show previously worked on private radio, but in 2012 it won the Sony Gold Award for a breakfast show hosted on Real Radio with co-sponsor Gary Philipson.

The cause of her death is still under investigation, but the coroner has issued a provisional death certificate with “AstraZeneca COVID-19 virus vaccination complications” as a consideration.

AstraZeneca logo
On March 10, 2021, this illustration shows a vial and syringe labeled “AstraZeneca COVID-19 Coronavirus Vaccine” in front of the displayed AstraZeneca logo. (Dado Ruvic / Reuters, illustration / file photo)

The Medicines and Healthcare products Regulatory Authority (MHRA), the UK drug regulator that approved the vaccine, expressed its condolences.

A MHRA spokeswoman said, “I’m sad to know Lisa Shaw’s death and I’m thinking with her family.”

“As with suspected serious side effects, if fatal consequences are reported, they will be fully evaluated by the MHRA, including a detailed postmortem evaluation where possible.

“A detailed and rigorous review of reports of thrombosis concomitant with thrombocytopenia is underway.”

According to MHRA Latest report As for the side effects of the vaccine, by May 19, 58 people in the UK had died of blood clots after injection of AstraZeneca.

The MHRA reported 332 thrombotic events in which platelet counts decreased after the jab. These events occurred in 180 women and 151 men between the ages of 18 and 93.

AstraZeneca vaccines have been scrutinized for thrombotic problems, with younger people having a higher incidence.

To prevent cases of blood clots, people under the age of 40 in the United Kingdom are offered an alternative to the AstraZeneca vaccine.

However, the British government has repeatedly emphasized that the benefits of the AstraZeneca vaccine continue to outweigh the risks for most people.

By May 19, MHRA estimates that by May 19, 24.2 million people had received the AstraZeneca vaccine for the first time and 10.7 million had received the second dose.

PA contributed to this report.

Posted on